4.8 Review

The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs

期刊

JOURNAL OF HEPATOLOGY
卷 75, 期 -, 页码 S3-S13

出版社

ELSEVIER
DOI: 10.1016/j.jhep.2020.11.042

关键词

Liver; Cirrhosis; Public health; Epidemiology; DALY; QALY

资金

  1. Novo Nordisk Foundation [NNF18OC0054612]

向作者/读者索取更多资源

Cirrhosis is a significant burden on public health, with hepatitis C, alcohol, and hepatitis B being the main contributors globally. In poorer countries, hepatitis B infection is the primary cause, while alcohol and hepatitis C are dominant in more affluent countries.
Cirrhosis is a burden on the individual and on public health. The World Health Organization's metric of public health burden is the disability-adjusted life-year (DALY), the sum of years of life lost due to premature death and years of life lived with disability. The more DALYs attributable to a disease, the greater its burden on public health. Cirrhosis was responsible for 26.8% fewer DALYs in 2019 than in 1990, which is positive, but the reduction in DALYs across the spectrum of diseases in and outside the liver was 34.4%. Hepatitis C (26% of DALYs), alcohol (24%), and hepatitis B (23%) contribute almost equally to the global burden of cirrhosis. The contribution from non-alcoholic fatty liver disease (8%) is small but increasing. There is substantial global variation in the burden and causes of cirrhosis. We find that the poorest countries carry the greatest burden of cirrhosis, and that this burden is primarily caused by cirrhosis from hepatitis B infection. Interventions targeting hepatitis B infection are known, but not fully implemented. In more affluent countries, alcohol and hepatitis C are the dominant causes of cirrhosis, but non-alcoholic fatty liver will likely become a dominant cause of cirrhosis in parallel with the increasing prevalence of obesity. We also argue that the World Health Organization underestimates the public health burden associated with cirrhosis because it assigns zero disability to compensated cirrhosis and considers decompensated cirrhosis as only mildly disabling. (C) 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据